This is the second part of an interview with Elixinol CEO Oliver Horn. Read his insights on leadership here. In a recent presentation, you said the company was “well-positioned to navigate the regulatory environment that is dynamic, and we remain very positive that regulatory changes are working in our... Read more

(A version of this story first appeared on Marijuana Business Daily.) Peru is giving hemp-derived medicines the green light, with commercialization imminent once the respective companies obtain the necessary import permits. Two hemp-derived products are registered as “cannabis-derived natural health products” in Peru. Toronto-headquartered Ramm Pharma, a company with... Read more